Srodki Pieniężne I Ekwiwalent Zmiana Data
Cara Therapeutics USD 19.85M 883K 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
Cronos Group USD 467.02M 354.84M 2026-06
RedHill Biopharma USD 2.87M 1.75M 2025-06